PATRICK D KUHLMAN
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology GREENVILLE, SC NPI 1386064640
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SC Incyte Corporation All categories
General Payments — all program years on this page
$3,028.50
- Category: General Payments
- Program years: PY2019–2024
- Record count: 84
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $923.91 across 40 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $923.91 | 40 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $124.56 | 1 |
| PFIZER INC. | $99.49 | 4 |
| Daiichi Sankyo Inc. | $67.74 | 3 |
| Acerta Pharma LLC | $65.66 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $64.73 | 3 |
| Janssen Biotech, Inc. | $62.02 | 3 |
| Gilead Sciences, Inc. | $61.52 | 2 |
| Merck Sharp & Dohme Corporation | $51.90 | 2 |
| E.R. Squibb & Sons, L.L.C. | $45.94 | 3 |
| Astellas Pharma US Inc | $40.40 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $27.35 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.40 | 1 |
| Genentech USA, Inc. | $21.63 | 1 |
| Celgene Corporation | $19.33 | 1 |
| BioCryst US Sales Co., LLC | $18.24 | 1 |
| BeiGene USA, Inc. | $17.76 | 1 |
| Rigel Pharmaceuticals, Inc. | $17.60 | 1 |
| ARRAY BIOPHARMA INC | $17.52 | 1 |
| EISAI INC. | $16.35 | 1 |
| Kyowa Kirin, Inc. | $15.88 | 1 |
| ADC Therapeutics America, Inc. | $14.41 | 1 |
| Regeneron Healthcare Solutions, Inc. | $14.29 | 1 |
| Exelixis Inc. | $13.19 | 1 |
By program year
Records — PY2024 (40)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.